Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Szarek

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Psychiatric Hospital|March 5, 1989
Do DSM-III criteria for major depression define distinct subtypes?J W Goethe, B L Szarek
The Journal of Nervous and Mental Disease|January 1, 1990
Dose-related paranoid reaction associated with fluoxetineG E Mandalos, B L Szarek
Journal of Clinical Psychopharmacology|April 22, 1999
New-onset panic attacks in a patient treated with olanzapineG E Mandalos, B L Szarek
The American Journal of Psychiatry|July 1, 1988
Clomipramine for obsessive-compulsive symptomsB L Szarek, J W Goethe
The Journal of Nervous and Mental Disease|June 1, 1992
Response to Chiles and colleaguesB L Szarek, J W Goethe
The Journal of Nervous and Mental Disease|November 1, 1993
A comparison of weight changes with fluoxetine, desipramine, and amitriptyline: a retrospective study of psychiatric inpatientsB L Szarek, D M Brandt
Journal of Clinical Psychopharmacology|April 1, 1984
Use of clomipramine in treatment of obsessive-compulsive symptomatologyC F Stroebel, B L Szarek, B C Glueck
Journal of Clinical Psychopharmacology|February 1, 1997
Unsuccessful reexposure to clozapineB L Szarek, J W Goethe, P G Pentz
The Journal of Nervous and Mental Disease|August 1, 1988
A comparison of adequately vs. inadequately treated depressed patientsJ W Goethe, B L Szarek, W L Cook
Connecticut Medicine|October 23, 1997
Physician compliance with practice guidelinesJ W Goethe, H I Schwartz, B L Szarek
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Psychiatric Hospital|March 5, 1989
Do DSM-III criteria for major depression define distinct subtypes?J W Goethe, B L Szarek
The Journal of Nervous and Mental Disease|January 1, 1990
Dose-related paranoid reaction associated with fluoxetineG E Mandalos, B L Szarek
Journal of Clinical Psychopharmacology|April 22, 1999
New-onset panic attacks in a patient treated with olanzapineG E Mandalos, B L Szarek
The American Journal of Psychiatry|July 1, 1988
Clomipramine for obsessive-compulsive symptomsB L Szarek, J W Goethe
The Journal of Nervous and Mental Disease|June 1, 1992
Response to Chiles and colleaguesB L Szarek, J W Goethe
The Journal of Nervous and Mental Disease|November 1, 1993
A comparison of weight changes with fluoxetine, desipramine, and amitriptyline: a retrospective study of psychiatric inpatientsB L Szarek, D M Brandt
Journal of Clinical Psychopharmacology|April 1, 1984
Use of clomipramine in treatment of obsessive-compulsive symptomatologyC F Stroebel, B L Szarek, B C Glueck
Journal of Clinical Psychopharmacology|February 1, 1997
Unsuccessful reexposure to clozapineB L Szarek, J W Goethe, P G Pentz
The Journal of Nervous and Mental Disease|August 1, 1988
A comparison of adequately vs. inadequately treated depressed patientsJ W Goethe, B L Szarek, W L Cook
Connecticut Medicine|October 23, 1997
Physician compliance with practice guidelinesJ W Goethe, H I Schwartz, B L Szarek
Pageof 2